Samsung Group in talks to buy Biogen (BIIB) - Korean Economic Daily
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
Samsung Group is in talks to buy Biogen (NASDAQ: BIIB) for more than $40 billion, the Korean Economic Daily reported Wednesday afternoon citing investment banking sources.
The report said Biogen approached Samsung about a deal valued at around $42 billion. Biogen's current market cap is around $35 billion.
"Samsung is at the negotiating table with the sell side to acquire Biogen," a senior official at a global investment bank told The Korea Economic Daily on Dec. 29.
A spokesperson for Biogen told StreetInsider.com it does not comment on market rumors or speculation related to rumors Samsung Group is in talks to buy it.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caribou Biosciences to halt CAR-T programs, explore sale
- Navitas Semiconductor closes acquisition of Claros to expand AI power
- Zeta Global to acquire data firm Digital Audience
Create E-mail Alert Related Categories
Hot M&A, Mergers and Acquisitions, RumorsRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
